Fig. 11
Schematic model for the synergism of IDH1-mutant metabolite D-2-hydroxyglutarate and temozolomide in anti-glioma via down-regulating ITGB4/PI3K/AKT and increasing DNA double-strand break.
Fig. 11 | Cell Death Discovery
Schematic model for the synergism of IDH1-mutant metabolite D-2-hydroxyglutarate and temozolomide in anti-glioma via down-regulating ITGB4/PI3K/AKT and increasing DNA double-strand break.
